WHO Prequalifies The First Vaccine Against Mpox Dr. Bhumika Maikhuri18 Sept 2024 8:00 AM ISTThe World Health Organization (WHO) has announced the MVA-BN vaccine as the first vaccine against mpox to be added to its prequalification list.“This...
Experimental mRNA Cancer Vaccine Shows Potential for Advanced Stage Cancer Patients in Phase 1 Trial Dr. Garima Soni16 Sept 2024 8:00 AM ISTInterim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid...
Moderna lays out plan to slice research and development spending MD Bureau Team15 Sept 2024 10:45 AM ISTWashington: Shares of Moderna tumbled after the vaccine developer said it was cutting research and development spending and pushed back its time...
Moderna forecasts lower sales next year, shares near four-year low MD Bureau Team14 Sept 2024 11:34 AM ISTLondon: Moderna pushed back its break-even goal by two years on Thursday as it delayed the timeline for developing several key products and predicted...
Bavarian Nordic sees potential to ramp up mpox vaccine capacity MD Bureau Team14 Sept 2024 9:15 AM ISTCopenhagen: Bavarian Nordic said on Thursday it could supply 13 million doses of its mpox vaccine by the end of 2025, up from a previous forecast...
After positive midstage trial, GSK moves mRNA flu vaccine to late-stage trials MD Bureau Team13 Sept 2024 2:56 PM ISTBritish drugmaker GSK announced on Thursday positive results from a mid-stage trial of its seasonal influenza vaccine programme using the...
Indian Immunologicals, ICMR to develop Zika Vaccine Kajal Rajput13 Sept 2024 11:44 AM ISTHyderabad: Indian Immunologicals Limited (IIL) and the Indian Council of Medical Research (ICMR) have signed a Memorandum of Association (MoA) to...
JnJ Tremfya receives USFDA approval for adults with moderately to severely active ulcerative colitis Ruchika Sharma12 Sept 2024 12:30 PM ISTHorsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA (guselkumab) for the treatment of...
One dose of modified smallpox vaccine effective in preventing mpox infection, reveals BMJ study Dr. Kamal Kant Kohli12 Sept 2024 5:00 AM ISTOne dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox vaccine is moderately effective in preventing mpox infection and should be made...
New RSV vaccine can result in individual and societal cost savings, benefits for elderly: Study Dr. Kamal Kant Kohli6 Sept 2024 8:30 PM ISTVaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of...
US FDA approves Emergent's smallpox vaccine for people at high risk of mpox MD Bureau Team1 Sept 2024 12:00 PM ISTLondon: The U.S. Food and Drug Administration (FDA) has approved expanded use of Emergent BioSolutions' ACAM2000 smallpox vaccine to include...
FDA authorizes Novavax's updated COVID vaccine targeting JN.1 strain MD Bureau Team1 Sept 2024 10:45 AM ISTBengaluru: The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's COVID...
